🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04449666
Recruiting Observational

Hippocampal Volume and Memory Functions in Aneurysmal Subarachnoid Hemorrhage

NCT04449666 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2020-06-15
Last updated
2025-09-19

Condition(s) studied

Neurologic DisorderSubarachnoid Hemorrhage, Aneurysmal

Investigational drug(s) / intervention(s)

Neuropsychological assessment and structural MRI

Neuropsychological assessment and structural MRI: Complex neuropsychological assessment testing attentional and memory functions. Additionally, a structural MRI is measured.

Study summary

Neuropsychological and functional long-term consequences of subarachnoid hemorrhages (SAH) represent a great challenge, since sometimes considerable cognitive deficits occur without evidence of substantial brain damage. In this study, we want to examine if the frequently observed memory deficits are associated with hippocampal atrophy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * neurological rehabilitation patients in phase B - D * at minimum eight weeks after disease onset * aneurysmal subarachnoid hemorrhage (Hunt \& Hess grade I or II) * written consent from the patient's legal representative * exclusion of pregnancy Exclusion Criteria: * insufficient cardiorespiratory stability * previous brain damage * mental disorders (dementia, depression) * colonization with multi-resistant pathogens * MRI contraindications * claustrophobia * weight \> 120 kg

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
BDH-Clinic Hessisch Oldendorf Hessisch Oldendorf Germany Recruiting

More BDH-Klinik Hessisch Oldendorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04449666 on ClinicalTrials.gov ↗ ← All trials in Germany